A new scientific association promotes use in mainstream medicine
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
From the American Heart Association 2007 meeting
Poster data presented at Scientific Sessions 2007 have demonstrated that the application of clinical practice modifications, combined with advanced electronic technologies, can improve the care of patients at risk for sudden cardiac arrest (SCA).
Quantitative PET imaging
Visual analysis of PET scans for non-Hodgkin lymphoma may be improved by using standardised uptake value in monitoring response to treatment, according to research published in the Journal of Nuclear Medicine.
Starving a tumour
Every developing tissue is supplied by blood vessels with oxygen and nutrients. Tumours grow far more quickly than normal tissues, so have a greater need of nutrients, which is why tumour cells begin to produce growth factors that stimulate the formation of blood vessels.
Carestream
In May, Kodak became Carestream. Then, Carestream was bought by Onex. This shapes part of a significant Health portfolio.
MEDICA MEDIA 2007
Hall 16 While it is often possible to determine drug costs (or at least the defined daily dose) it is often impossible to determine actual costs of a particular case.
The IVAM
IVAM is an international association of companies and institutes that specialise in microtechnology, nanotechnology and advanced materials.
Infant receives first systemic therapy to treat RDEB
Children with recessive dystrophic epidermolysis bulosa (RDEB) lack a protein that binds the skin to the body, resulting in fragile skin that sloughs off with little movement or friction.
New medical technology centre to target artificial organs
Switzerland - An Artificial Organ Centre for Biomedical Engineering Research has been set up at the University of Bern, drawing together its established areas of expertise in medical technology.
Life's choices - Balancing work and leisure
Radiologist Dr Myriam Hunink is a Professor in the Epidemiology and Biostatistics and the Radiology Departments at the Erasmus MC in the university medical centre, Rotterdam, the Netherlands, where she is also project leader for several research projects focused on radiology and epidemiology.
Medical technology trends
As in past years, this year's MEDICA is one of the most important stages for the medical technology industry. International manufacturers will do a song and dance to dazzle the international clientele. As Managing Director of the German Electrical and Electronic Manufacturers' Association (Deutscher Zentralverband Elektrotechnik- und Elektronikindustrie e.V. - ZVEI), Hans-Peter Bursig, is well…
Health telematics
Telematics appears to offer solutions for certain complex therapies - and for issues that will become central as populations further swell with age.
Taxus produces similar outcomes in men & women
Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.
The 64-MSCT in the emergency room
For 2 1/2 years we have had the opportunity to use a 64-MSCT in our emergency department at the Brüder-Krankenhaus Trier, the biggest institution of the Brothers of Charity and academic teaching hospital at the University of the State Capital of Mainz.
Euro 900 million for molecular imaging R&D
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
The European Study of Screening for Prostate Cancer (ERSPC)
The ERSPC is the world's biggest study of screening of prostate cancer. It involves up to 260,000 men, 220,000 of them in the age group 55-75 years old. Professor Chris Bangma, Director of the ERSPC and Chairman of the urology department at the Erasmus Medical Centre, Rotterdam (headquarters of the ERSPC) explains the study's background and aims
Tracking TB bacterium from space
TB bacterium have a unique chemical coating and it is hoped that a tiny gas chromatograph mass spectrometer (GC-MS) - a detection device* developed for the Beagle 2, on its mission to Mars - will be able to pick this out from space, in a project run by Britain's Open University and the London School of Hygiene and Tropical Medicine.
Embracing Excellence in Prostate and Kidney Cancer
The first European Multidisciplinary Meeting on Urological Cancers will take place in Barcelona, Spain, November 2nd to 4th, 2007. The meeting is co-organized by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO).
Stem Cell therapy repairs lungs in mice
At the Annual Congress of the European Respiratory Society (ERS), which took place in Stockholm, September 15-19, 2007, researchers from the Imperial College London, UK, presented their study about the successful implantation of lung cells grown from embryonic stem cells into the lungs of mice. In future, this method could be used for the treatment of human lung diseases.
Progenitor Cell Transfer to Repair the Heart after Myocardial Infarction
By Stefan P. Janssens, MD, PhD Russian summary and complete article in English.
SECA - Partnership for Heart
Research Project in Telemedicine
Healing skin wounds
Researchers define the role of signal molecule c-Met
Could a virtual game help pandemic studies?
USA - Online game worlds might prove useful for the study of a spread of human infectious diseases, according to scientists Eric Lofgren and Nina Fefferman, of Rutgers University (Piscataway, NJ, USA) and Tufts University (Boston, MA, USA).
ESMO Lifetime Achievement Award
The Dutch Cancer Institute (NKI) has won the ESMO Lifetime Achievement Award, presented by The European Society for Medical Oncology, for its `excellent translational research into breast cancer´.
Dynamic Contrast Enhanced Ultrasonography (DCE-US)
Early functional evaluation of new treatments in oncology is of major importance. Overall survival rate is the best criterion for assessing treatment, but unfortunately it calls for lengthy follow-up whereas treatment efficacy must be ascertained as soon as possible. The morphological criteria normally used (WHO or RECIST) do not lend themselves easily to new therapies which often induce lesion…
